Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
08/18/2005 | US20050182093 Novel compounds |
08/18/2005 | US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents |
08/18/2005 | US20050182045 Fused ring 4-oxopyrimidine derivative |
08/18/2005 | US20050182040 Benzamide derivatives |
08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
08/18/2005 | US20050181072 Use of essential oils for combating gi tract infection by helicobacter-like organisms |
08/18/2005 | US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
08/18/2005 | US20050180965 Heat-reversible composition treating hyposalia and asialia |
08/18/2005 | US20050180963 Probiotic propionibacterium |
08/18/2005 | US20050180959 Kinases involved in the regulation of energy homeostasis |
08/18/2005 | US20050180929 Ozone treatment of root canals |
08/18/2005 | CA2558877A1 Solifenacin succinate-containing composition |
08/18/2005 | CA2555469A1 Use of relaxin-3 for promoting food intake, increasing body weight gain, increasing fat weight and for others |
08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
08/18/2005 | CA2555304A1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome |
08/18/2005 | CA2554683A1 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
08/18/2005 | CA2554260A1 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole |
08/18/2005 | CA2554091A1 Prodrug comprising 5-aminosalicylate glycoside |
08/18/2005 | CA2554030A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders |
08/18/2005 | CA2547843A1 Composition comprising polymeric material and uses thereof |
08/17/2005 | EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation |
08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
08/17/2005 | EP1563842A1 Simarouba amara and/or Momordica charantia extracts for the treatment of coccidiosis in poultry |
08/17/2005 | EP1563835A1 Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
08/17/2005 | EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
08/17/2005 | EP1562615A1 Oral and dental composition |
08/17/2005 | EP1562614A1 High affinity receptors for helicobacter pylori and use thereof |
08/17/2005 | EP1562572A2 Pharmaceutical solutions of modafinil compounds |
08/17/2005 | EP1436380B1 Composition comprising a lactobacillus strain and uses thereof |
08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
08/17/2005 | EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
08/17/2005 | EP1315496B1 The treatment of inflammatory disorders |
08/17/2005 | EP1294372B1 Dry powder formulation comprising racecadotril |
08/17/2005 | EP1285271B1 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
08/17/2005 | EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
08/17/2005 | EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
08/17/2005 | EP1087943B1 Therapeutic biaryl derivatives |
08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
08/17/2005 | EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity |
08/17/2005 | EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
08/17/2005 | EP0837880B1 Enamel matrix related polypeptide |
08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
08/17/2005 | EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
08/17/2005 | CN1656125A Extraction of unmilled psyllium |
08/17/2005 | CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
08/17/2005 | CN1656098A Fused bicyclic pyrimidine derivatives |
08/17/2005 | CN1656096A Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
08/17/2005 | CN1656091A Tetrahydropyran derivatives |
08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
08/17/2005 | CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
08/17/2005 | CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
08/17/2005 | CN1656070A Melanocortin receptor ligands |
08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
08/17/2005 | CN1655807A Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition |
08/17/2005 | CN1655805A Chewable compositions containing a gel-forming extract of psyllium |
08/17/2005 | CN1655797A Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone |
08/17/2005 | CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
08/17/2005 | CN1655784A Use of compounds that are effective as selective opiate receptor modulators |
08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
08/17/2005 | CN1655776A Anti-constipation composition |
08/17/2005 | CN1655774A Bis-aromatic alkanols |
08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
08/17/2005 | CN1655675A Combination therapy using trefoil peptides |
08/17/2005 | CN1654066A Kidney-nourishing yang-strengthening medicine |
08/17/2005 | CN1654064A Chinese medicinal composition for treating respiratory illness and digestive illness |
08/17/2005 | CN1654063A Chinese medicinal composition for treating irritable bowel syndrome and its preparation method |
08/17/2005 | CN1654057A Chinese medicine composition for treating acute cholecystitis and preparing method thereof |
08/17/2005 | CN1654056A Chinese medicine composition for peridentitis and preparing method thereof |
08/17/2005 | CN1654053A Chinese medicinal tonifying wine with kidney tonifying, qi sooting, kidney invigorating, blood benefiting, kidney nourishing, essence benefiting functions |
08/17/2005 | CN1654052A Chinese medicinal tonifying wine with kidney warming, yang activating, cold dispersing, pain relieving, blood activating, qi circulation promoting functions |
08/17/2005 | CN1654051A Chinese medicinal tonifying wine capable of chest oppression soothing, qi regulating, stomach regulating, tendons relaxing and activating functions |
08/17/2005 | CN1654049A Chinese medicinal tonifying wine for preventing and treating pestilence, cholera, abdominal pain and stomach stuff |
08/17/2005 | CN1654048A Chinese medicinal tonifying wine112 |
08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
08/17/2005 | CN1214817C Coupling factor 6 inhibitor and potentiator and use thereof |
08/17/2005 | CN1214809C Drip pills for curing aphtha and its preparing method |
08/17/2005 | CN1214807C Toxicant-elimination medicine |
08/17/2005 | CN1214800C Shanbao Oil (contg. plant seed oil and insect power) capsule |
08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
08/16/2005 | US6930093 [1- beta -D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, [1- beta -ribofuranosyl-1H-1,2,4-triazole-3-amidine,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-amidine |
08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
08/16/2005 | US6929790 Containing a zinc compound containing free available zinc ion and at least one stabilized oxidation potential raising compound, stored separately and mixed prior to using the oral composition. |